TB Vaccines Market Research Report 2019 ď ľ
Published On : 2 April 2019
E-mail: help@grandresearchstore.com
Report Studies Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defense against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-GuĂŠrin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defense against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%. Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
E-mail: help@grandresearchstore.com
By Manufacture
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSigna E-mail: help@grandresearchstore.com
TB Vaccines Market By Application 6 5 4 3 2 1 0
Application1
Application2 2018
Application3 2025
Application4
growth
E-mail: help@grandresearchstore.com
TB Vaccines Market Value
CAGR 9.4% (2018 - 2023)
xx
2018
xx
2019
xx
2020
xx
2021
xx
2022
xx
2023
xx
2024
xx
2025
E-mail: help@grandresearchstore.com
Get in touch
+91 8087042414 (Asia)
+1 (646) 781 7170 (International)
www.grandresearchstore.com
help@grandresearchstore.com
Click here to know mor e about report
Follow us: